BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37337439)

  • 1. Promising results for treatment of severe chronic hand eczema with dupilumab.
    Brans R
    Br J Dermatol; 2023 Sep; 189(4):360-361. PubMed ID: 37337439
    [No Abstract]   [Full Text] [Related]  

  • 2. Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab.
    Loman L; Diercks GFH; Schuttelaar MLA
    Contact Dermatitis; 2021 Feb; 84(2):124-127. PubMed ID: 32864776
    [No Abstract]   [Full Text] [Related]  

  • 3. The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry.
    Voorberg AN; Romeijn GLE; de Bruin-Weller MS; Schuttelaar MLA
    Contact Dermatitis; 2022 Aug; 87(2):185-191. PubMed ID: 35279856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
    Fowler JF; Graff O; Hamedani AG
    J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational Chronic Hand Dermatitis in Hospital Environment Successfully Treated with Dupilumab: A Case Report.
    Gan H; Gao YD
    Iran J Allergy Asthma Immunol; 2022 Aug; 21(4):484-487. PubMed ID: 36243937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
    Hendricks AJ; Yosipovitch G; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
    Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
    Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alitretinoin: in severe chronic hand eczema.
    Garnock-Jones KP; Perry CM
    Drugs; 2009 Aug; 69(12):1625-34. PubMed ID: 19678713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hand eczema with dupilumab-A retrospective follow-up study.
    Olesen CM; Yüksel YT; Zachariae C; Lund TT; Agner T; Petersen TS; Thyssen JP
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e557-e559. PubMed ID: 36463422
    [No Abstract]   [Full Text] [Related]  

  • 10. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
    Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
    Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alitretinoin: A Review in Severe Chronic Hand Eczema.
    Blair HA; Scott LJ
    Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alitretinoin: a new treatment option for chronic refractory hand eczema].
    Molin S; Ruzicka T
    Hautarzt; 2008 Sep; 59(9):703-4, 706-9. PubMed ID: 18704345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dupilumab in the management of idiopathic chronic eczematous eruption of aging.
    Shahriari N; Strober B; Shahriari M
    J Am Acad Dermatol; 2020 Nov; 83(5):1533-1535. PubMed ID: 32679275
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral Alitretinoin in the Treatment of Severe Refractory Chronic Hand Eczema in the Spanish National Health System: Description and Analysis of Current Clinical Practice.
    Urrutia S; Roustan G; Plazas MJ; Armengol S; Paz S; Lizan L
    Actas Dermosifiliogr; 2016 Mar; 107(2):142-8. PubMed ID: 26363930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alitretinoin for the treatment of severe chronic hand eczema.
    Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
    Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
    Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
    Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment.
    Lynde C; Cambazard F; Ruzicka T; Sebastian M; Brown TC; Maares J
    Clin Exp Dermatol; 2012 Oct; 37(7):712-7. PubMed ID: 22731739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study.
    Oosterhaven JAF; Voorberg AN; Romeijn GLE; de Bruin-Weller MS; Schuttelaar MLA
    J Dermatol; 2019 Aug; 46(8):680-685. PubMed ID: 31187925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alitretinoin in chronic hand eczema: summary of clinical trials].
    Richard MA
    Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S111-23. PubMed ID: 21185982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab for severe generalized eczematous eruption complicating common variable immunodeficiency.
    Votquenne N; Dupire G; Michel O; Ben Said B
    Eur J Dermatol; 2021 Feb; 31(1):93-94. PubMed ID: 33586652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.